Biotech

All Articles

ArsenalBio raises $325M, rotates far from former lead possession

.Toolbox Biosciences is proceeding up. The tissue therapy provider has actually added on $325 millio...

Lilly- supported weight management biotech files IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has filed to...

Aelis' cannabis usage drug fails period 2b, driving Indivior to reassess $100M choice

.Aelis Farma's chances of getting a quick, positive choice on a $one hundred million possibility rem...

ProKidney halts phase 3 test not required for tissue treatment approval

.ProKidney has stopped some of a set of period 3 tests for its own tissue treatment for kidney ailme...

Vaxcyte rises on 'sensational' 31-valent PCV win against Pfizer

.Vaxcyte introduced what experts referred to as "impressive" period 1/2 information for its own 31-v...

Recursion's human brain illness trial presents insufficient proof of efficacy

.Recursion has stumbled through a very early examination of its tech-enabled method to drug explorat...

Acepodia, Pfizer click on together for chemistry-based cell therapy

.Phone it a situation of good chemistry: Acepodia, a biotech based upon Nobel Prize-winning science,...

Praxis epilepsy drug minimizes seizures in phase 2 hearing

.Praxis Precision Medicines has scored one more midphase gain in epilepsy this year, with its salt s...

Three directors resign as Dyne messages mixed information for DMD prospect

.After running away a medical hold numerous years back, Dyne Therapy has actually revealed new perio...

Arrowhead fires off phase 3 information in uncommon metabolic ailment in advance of market encounter Ionis

.Arrowhead Pharmaceuticals has actually presented its own give before a prospective showdown along w...